Peri-operative SLOG for Localized Pancreatic Cancer
NCT05048524
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
64
Enrollment
OTHER
Sponsor class
Conditions
Pancreatic Ductal Adenocarcinoma
Pancreas Cancer
Interventions
DRUG:
S-1, leucovorin, oxaliplatin and gemcitabine
Sponsor
National Health Research Institutes, Taiwan